NDC Package 68071-5102-0 Yosprala

View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68071-5102-0
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Yosprala
Usage Information:
This combination product contains two medications: aspirin and omeprazole. It is used to reduce the risk of stroke or heart attack in people who have had "mini-strokes" (transient ischemic attacks), or a stroke due to a blood clot, or who have heart disease. This product is used by people who are at risk for developing ulcers while taking aspirin. Aspirin belongs to a class of drugs known as antiplatelets. It has many uses, such as for pain relief or to reduce a fever. In low doses (such as this product), it is used to prevent harmful blood clots that can cause a stroke or heart attack. It works by stopping platelets in your blood from clumping together to form clots. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). It works by decreasing the amount of acid your stomach makes. This effect helps prevent ulcers and other stomach-related problems (such as heartburn) that can be caused by aspirin. This medication contains a delayed-release form of aspirin. It should not be used to treat conditions that require an immediate-release form of aspirin, such as right after a heart attack or before certain heart procedures (such as percutaneous coronary intervention-PCI). Also, this combination product is not the same as taking aspirin and omeprazole separately.
11-Digit NDC Billing Format:
68071510200
NDC to RxNorm Crosswalk:
  • RxCUI: 1811631 - aspirin 81 MG / omeprazole 40 MG Delayed Release Oral Tablet
  • RxCUI: 1811631 - ASA 81 MG / Omeprazole 40 MG Delayed Release Oral Tablet
  • Labeler Name:
    Nucare Pharmaceuticals,inc.
    Sample Package:
    No
    Start Marketing Date:
    07-17-2019
    Listing Expiration Date:
    12-31-2022
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68071-5102-0?

    The NDC Packaged Code 68071-5102-0 is assigned to a package of 30 tablet, film coated in 1 bottle of Yosprala, labeled by Nucare Pharmaceuticals,inc.. The product's dosage form is and is administered via form.

    Is NDC 68071-5102 included in the NDC Directory?

    No, Yosprala with product code 68071-5102 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Nucare Pharmaceuticals,inc. on July 17, 2019 and its listing in the NDC Directory is set to expire on December 31, 2022 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68071-5102-0?

    The 11-digit format is 68071510200. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-168071-5102-05-4-268071-5102-00